Article Versions Notes

Skowron MA, Niegisch G, Albrecht P, Van Koeveringe G, Romano A, Albers P, Schulz WA, Hoffmann MJ. Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines. International Journal of Molecular Sciences. 2017; 18(8):1680. https://doi.org/10.3390/ijms18081680

Skowron, Margaretha A., Günter Niegisch, Philipp Albrecht, Gommert Van Koeveringe, Andrea Romano, Peter Albers, Wolfgang A. Schulz, and Michèle J. Hoffmann. 2017. "Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines" International Journal of Molecular Sciences 18, no. 8: 1680. https://doi.org/10.3390/ijms18081680

Skowron, M. A., Niegisch, G., Albrecht, P., Van Koeveringe, G., Romano, A., Albers, P., Schulz, W. A., & Hoffmann, M. J. (2017). Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines. International Journal of Molecular Sciences, 18(8), 1680. https://doi.org/10.3390/ijms18081680